Clinical Trial Update: A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease. [Phase 1]

View source ↗

Summary

A Phase 1b study evaluating AZD4144 in participants with established atherosclerotic cardiovascular disease and chronic kidney disease has completed, focusing o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• AZD4144

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease | Phase 1 | Status: COMPLETED